Sanofi issued the following announcement on Feb. 28.
Sanofi U.S. today announced that it has reached an $11.85 million settlement agreement with the federal government to resolve an investigation relating to certain financial donations made in 2015 and 2016 to an independent charity patient assistance foundation that aided patients living with multiple sclerosis.
As part of the settlement, Sanofi U.S. has also entered into a Corporate Integrity Agreement (CIA) with the Office of the Inspector General of the U.S. Department of Health and Human Services. Many of the requirements are already incorporated into the Company's existing U.S. compliance program. Sanofi is committed to compliance, and the Company's compliance program is regularly enhanced to ensure its controls meet or exceed the complex and evolving legal, regulatory, and industry requirements, as well as the expectations of patients and providers.
This resolution reflects the Company's desire to put this investigation behind it and to continue its focus on the needs of patients. It does not constitute any admission of guilt.
Sanofi believes all individuals deserve access to medicines prescribed by their physicians. Donations to independent charitable organizations can provide significant assistance to patients with their co-payments for prescriptions, and the Company believes these programs help patients lead healthier lives. Sanofi U.S. continues to donate to independent charity patient assistance foundations as part of its efforts to help ensure patients have access to important medicines as well as maintains other programs to assist patients in this regard.
Sanofi is dedicated to supporting people through their health challenges. We are a global biopharmaceutical company focused on human health. We prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. We stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.
With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.
Original stars can be found here.